These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21387316)

  • 1. Monitoring lidocaine single-crystal dissolution by ultraviolet imaging.
    Østergaard J; Ye F; Rantanen J; Yaghmur A; Larsen SW; Larsen C; Jensen H
    J Pharm Sci; 2011 Aug; 100(8):3405-3410. PubMed ID: 21387316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance characteristics of UV imaging instrumentation for diffusion, dissolution and release testing studies.
    Jensen SS; Jensen H; Goodall DM; Østergaard J
    J Pharm Biomed Anal; 2016 Nov; 131():113-123. PubMed ID: 27589028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to dissolution testing by UV imaging and finite element simulations.
    Boetker JP; Rantanen J; Rades T; Müllertz A; Ostergaard J; Jensen H
    Pharm Res; 2013 May; 30(5):1328-37. PubMed ID: 23307418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microenvironmental pH measurement during sodium naproxenate dissolution in acidic medium by UV/vis imaging.
    Østergaard J; Jensen H; Larsen SW; Larsen C; Lenke J
    J Pharm Biomed Anal; 2014 Nov; 100():290-293. PubMed ID: 25194341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time UV imaging identifies the role of pH in insulin dissolution behavior in hydrogel-based subcutaneous tissue surrogate.
    Jensen SS; Jensen H; Cornett C; Møller EH; Østergaard J
    Eur J Pharm Sci; 2015 Mar; 69():26-36. PubMed ID: 25576795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time dissolution behavior of furosemide in biorelevant media as determined by UV imaging.
    Gordon S; Naelapää K; Rantanen J; Selen A; Müllertz A; Østergaard J
    Pharm Dev Technol; 2013; 18(6):1407-16. PubMed ID: 23136844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties.
    Bukovec P; Benkic P; Smrkolj M; Vrecer F
    Pharmazie; 2016 May; 71(5):263-8. PubMed ID: 27348970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
    Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
    Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of UV dissolution imaging to pharmaceutical systems.
    Brown B; Ward A; Fazili Z; Østergaard J; Asare-Addo K
    Adv Drug Deliv Rev; 2021 Oct; 177():113949. PubMed ID: 34461199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution study of nanocrystal powders of a poorly soluble drug by UV imaging and channel flow methods.
    Sarnes A; Østergaard J; Jensen SS; Aaltonen J; Rantanen J; Hirvonen J; Peltonen L
    Eur J Pharm Sci; 2013 Nov; 50(3-4):511-9. PubMed ID: 23999036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
    Qiao N; Wang K; Schlindwein W; Davies A; Li M
    Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matching phosphate and maleate buffer systems for dissolution of weak acids: Equivalence in terms of buffer capacity of bulk solution or surface pH?
    Cristofoletti R; Dressman JB
    Eur J Pharm Biopharm; 2016 Jun; 103():104-108. PubMed ID: 27032508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UV imaging in pharmaceutical analysis.
    Østergaard J
    J Pharm Biomed Anal; 2018 Jan; 147():140-148. PubMed ID: 28797957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process.
    Paulino AS; Rauber G; Campos CE; Maurício MH; de Avillez RR; Capobianco G; Cardoso SG; Cuffini SL
    Eur J Pharm Sci; 2013 May; 49(2):294-301. PubMed ID: 23557843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can crystal engineering be as beneficial as micronisation and overcome its pitfalls?: A case study with cilostazol.
    Sai Gouthami K; Kumar D; Thipparaboina R; Chavan RB; Shastri NR
    Int J Pharm; 2015 Aug; 491(1-2):26-34. PubMed ID: 26068197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of change in shape factor of a single crystal on its dissolution behavior.
    Dali MV; Carstensen JT
    Pharm Res; 1996 Jan; 13(1):155-62. PubMed ID: 8668667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured renal cells.
    Grover PK; Thurgood LA; Fleming DE; van Bronswijk W; Wang T; Ryall RL
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F355-61. PubMed ID: 18077596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the thermal, spectroscopic and drug dissolution properties of mefenamic acid and polyoxyethylene-polyoxypropylene solid dispersions.
    Andrews GP; Zhai H; Tipping S; Jones DS
    J Pharm Sci; 2009 Dec; 98(12):4545-56. PubMed ID: 19399827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the full potential of the biopharmaceutics classification system reached?
    Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
    Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.